boceprevir
Showing 1 - 25 of 26
Chronic Hepatitis C Genotype 1 Trial (Boceprevir, Placebo, peginterferon alfa-2b)
Completed
- Chronic Hepatitis C Genotype 1
- Boceprevir
- +3 more
- (no location specified)
Jan 15, 2021
Against HCV Based on Direct-acting Antivirals in Real-life
Completed
- Chronic Hepatitis C Infection
- Telaprevir
- +10 more
-
Seville, Andalusia, SpainValme University Hospital
Jun 22, 2022
Thrombocytopaenia Trial in Baltimore (Eltrombopag, Boceprevir, Telaprevir)
Completed
- Thrombocytopaenia
- Eltrombopag
- +2 more
-
Baltimore, MarylandGSK Investigational Site
Nov 8, 2017
Hepatitis C, Chronic, Cirrhosis Trial in Cleveland (Telaprevir, Boceprevir, Peg-IFN)
Completed
- Hepatitis C, Chronic
- Cirrhosis
- Telaprevir
- +3 more
-
Cleveland, OhioLouis Stokes Cleveland VA medical center
Mar 13, 2017
Hepatitis C, Chronic, HIV Trial in Vienna (Pegylated interferon alpha-2a, Ribavirin, Boceprevir)
Completed
- Hepatitis C, Chronic
- HIV
- Pegylated interferon alpha-2a
- +2 more
-
Vienna, AustriaDivision of Gastroenterology and Hepatology, Department of Inter
Feb 8, 2017
Hepatitis C Trial (boceprevir, PegIFN-2b, RBV)
Withdrawn
- Hepatitis C
- boceprevir
- +2 more
- (no location specified)
Mar 17, 2017
Hepatitis C Trial in Beverly Hills, Baltimore (Alisporivir, Boceprevir, Peginterferon alfa-2a)
Triple Combination Therapy With Boceprevir, Peginterferon
Terminated
- Hepatitis C, Chronic
- Boceprevir
- +3 more
-
Budapest, Hungary
- +6 more
Oct 18, 2016
HCV Infection, Liver Cirrhosis, Experimental Trial in France (Boceprevir, Peg-Interferon a-2b or Peg-Interferon a-2a, Ribavirin)
Completed
- HCV Infection
- Liver Cirrhosis, Experimental
- Boceprevir
- +2 more
-
Bordeaux, France
- +18 more
Jan 23, 2017
Hepatitis C, Human Immunodeficiency Virus Trial in Netherlands (Boceprevir)
Completed
- Hepatitis C
- Human Immunodeficiency Virus
- Boceprevir
-
Rotterdam, Zuid Holland, Netherlands
- +8 more
Mar 2, 2016
Dual And Triple Therapies Based on Peginterferon Alfa in Chronic
Completed
- Hepatitis C, Chronic
- Peg-IFN Alfa-2a
- +4 more
-
Antwerpen, Belgium
- +271 more
Feb 10, 2017
Hepatitis C Trial in Calgary (Boceprevir)
Completed
- Hepatitis C
- Boceprevir
-
Calgary, Alberta, CanadaUniversity of Calgary Liver Unit
Aug 22, 2015
Hepatitis C Infection, End Stage Renal Disease Trial (P-IFN alfa 2a, P-IFN alfa 2b, Ribavirin)
Withdrawn
- Hepatitis C Infection
- End Stage Renal Disease
- P-IFN alfa 2a
- +3 more
- (no location specified)
Sep 21, 2015
Treating Hispanic Patients Diagnosed With Hepatitis C Using
Terminated
- Hepatitis C Infection
- Boceprevir
-
Riverside, CaliforniaSouthern California Transplantation Institute Research Foundatio
Jun 27, 2015
Hepatitis, HIV/AIDS Trial in Washington, DC, Bethesda (Boceprevir, Peg-Interferon-alfa 2B, Ribavirin)
Terminated
- Hepatitis
- HIV/AIDS
- Boceprevir
- +2 more
-
Washington, DC, District of Columbia
- +1 more
Jul 9, 2015
Hepatitis C, HIV, COINFECTION Trial in Barcelona (boceprevir, Ribavirin, Peginterferon alfa-2a)
Completed
- Hepatitis C
- +2 more
- boceprevir
- +3 more
-
Barcelona, SpainHospital Clinic i Provincial de Barcelona
Jul 8, 2015
Genotype 4 Chronic Hepatitis C Infection Trial in Giza (Boceprevir, Peginterferon alfa-2b, ribavirin)
Unknown status
- Genotype 4 Chronic Hepatitis C Infection
- Boceprevir
- +2 more
-
Giza, EgyptTheodor Bilharz Research Institute
Dec 25, 2014
Hepatitis C Trial in London (Boceprevir, St John's Wort)
Completed
- Hepatitis C
- Boceprevir
- St John's Wort
-
London, United KingdomSt Stephen's AIDS Trust
Sep 23, 2014
Effect of Boceprevir on HCV-specific T Cell Responses
Completed
- Chronic Hepatitis C
- Boceprevir
-
Parma, ItalyUnit of Infectious Diseases and Hepatology
Nov 5, 2013